Shreya A Durve

Papers

1

Total Citations

20

H-Index

1

About

Shreya A. Durve is a rising voice in neurodegenerative disease research, with a focused expertise in amyotrophic lateral sclerosis (ALS). Her most-cited work, a comprehensive 2023 review on ALS treatment modalities, has already garnered 20 citations, signaling its importance in a rapidly evolving field. In this seminal paper, Durve synthesizes the current landscape of multidisciplinary care, emphasizing that ALS—a fatal condition marked by both upper and lower motor neuron degeneration—requires a collaborative therapeutic effort to delay respiratory failure. Her contribution lies in mapping the intersection of existing treatments and future prospects, offering a critical roadmap for clinicians and researchers alike. By highlighting the parallels between ALS and other dementia-type neuropathologies, Durve’s work underscores the need for integrated approaches to incurable diseases. Her review serves as a vital resource for students and scientists seeking to understand the state of ALS therapy, and her growing citation count reflects her emerging impact on the field. Durve’s dedication to advancing treatment paradigms positions her as a promising researcher in the fight against neurodegenerative disorders.

Research Focus

Key Achievements

1
H-Index
1
Papers
20
Total Citations
20
Avg Citations/Paper
🏆 Most Cited Paper
Exploring Advancements in the Treatment of Amyotrophic Lateral Sclerosis: A Comprehensive Review of Current Modalities and Future Prospects
20 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 11

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago